Search Results
323 items found for " Penelope Poyah"
Posts (220)
- Prostaglandin signaling in ciliogenesis and development
Recent studies have revealed that PGs play pivotal roles in embryo development, ciliogenesis, and organ During development, PGE2 signaling regulates embryogenesis, hepatocyte differentiation, hematopoiesis advances in understanding the functions and mechanisms of prostaglandin signaling in ciliogenesis, embryo development
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
December 2021 "Drug development is rarely trivial. typically require years to uncover the mechanisms of disease before they can even dare to contemplate the development Nevertheless, researchers have a host of new technologies at their disposal to develop targeted therapies Modern drug development approaches include a range of techniques leveraging structural biology, immunology
- The development of modulators for lysophosphatidic acid receptors: A comprehensive review
fibrosis, cancers, cardiovascular diseases and neuropathic pain, making it a promising target for drug development This article provides an extensive review on the current status of ligand development targeting LPA receptors
Other Pages (103)
- Single cell G-protein coupled receptor profiling of Transcription factor 21 expressing activated kidney fibroblasts
Kabir , Youan Liu , Suzanne L Advani , Phelopater Sedrak , Laurette Geldenhuys , Karthik K Tennankore , Penelope Poyah , Ferhan S Siddiqi , Andrew Advani .
- Developing a PROTAC to Degrade the Constitutively Active Onco-GPCR in Uveal Melanoma
About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Developing During her time at Providence College, she received the Walsh Grant Fellowship to develop novel methods
- Ep 96 with R. Scott Struthers
At Neurocrine, he initiated and led the effort to discover and develop orally active, nonpeptide GnRH Prior to Neurocrine, from 1995 to 1998, he co-founded ScienceMedia Inc. to develop eLearning solutions Between 1992 to 1995 he led contract research efforts at Biosym Technologies to develop and apply computational serves as board chair at Radionetics Oncology, a pharmaceutical company focused on the discovery and development